Veriteq (DIGA) 10-Q 20 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	15-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	VERITEQ
Document Type	10-Q
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		1,778,936,357
Amendment Flag	FALSE
Entity Central Index Key	924642
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
ASSETS
Cash	$16	$77
Restricted cash	12	12
Accounts receivable	60	11
Inventory	17	2
Other current assets	52	84
Total current assets	157	186
Property and equipment, net	33	35
Other assets	54	54
Intangible assets, net	1,425	1,470
Total assets	1,669	1,745
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	1,170	1,141
Accrued expenses (including $707 and $1,171 to related parties)	2,329	2,511
Notes payable, current portion, net of discounts (including $974 and $152 to related parties, and including $267 and $206 in default)	3,365	2,480
Liabilities for conversion options of convertible notes	951	930
Subordinated debt with an embedded conversion option, at fair value	225	316
Total current liabilities	8,040	7,378
Commitments and contingencies (note 12)
Notes payable, net of discount	294	286
Warrant liabilities at fair value	234	534
Estimated royalty obligations	440	440
Total liabilities	9,008	8,638
Stockholders' deficit:
Preferred stock ($0.01 par value; 4,998 shares authorized; 0 issued and outstanding	0	0
Common stock ($0.00001 par value; 10 billion shares authorized; 30,802 and 307 shares issued and outstanding)	0	0
Additional paid-in capital	15,363	15,000
Accumulated deficit	-24,543	-23,734
Total stockholders' deficit	-9,180	-8,734
Total liabilities and stockholders' deficit	1,669	1,745
Series D Preferred Stock [Member]
LIABILITIES AND STOCKHOLDERS' DEFICIT
Series D preferred stock ($0.01 par value; 1,841 shares outstanding)	$1,841	$1,841

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Accrued expenses to related parties (in Dollars)	$707	$1,171
Notes payable, net of discounts to related parties (in Dollars)	974	152
Notes payable, in default (in Dollars)	$267	$206
Preferred stock, par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	4,998,000	4,998,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common shares, par value (in Dollars per share)	$0.00	$0.00
Common shares, shares authorized	10,000,000,000	10,000,000,000
Common shares, shares issued	30,802,114	307,000
Common shares, shares outstanding	30,802,114	307,000
Series D Preferred Stock [Member]
Series D Preferred shares, par value (in Dollars per share)	$0.01	$0.01
Series D preferred stock, shares outstanding	1,841,000	1,841,000
Preferred stock, par value (in Dollars per share)	$0.01
Preferred stock, shares authorized	5,000,000
Preferred stock, shares outstanding	1,841

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Sales	$95,000	$74,000
Cost of goods sold, exclusive of depreciation and amortization, shown separately below	37,000	38,000
Gross profit	58,000	36,000
Operating Expenses:
Selling, general and administrative expenses	999,000	1,306,000
Development expenses	53,000	64,000
Depreciation and amortization expense	47,000	149,000
Total operating expenses	1,099,000	1,519,000
Operating loss	-1,041,000	-1,483,000
Other income (expenses)
Interest expense	-334,000	-461,000
Change in fair value of derivative instruments, net	566,000	6,625,000
Other expense		-56,000
Total other income	232,000	6,108,000
(Loss) income before income taxes	-809,000	4,625,000
Income tax benefit	0	0
Net (loss) income	($809,000)	$4,625,000
Net (loss) income per common share - basic (in Dollars per share)	($0.15)	$481.82
Net (loss) income per common share - diluted (in Dollars per share)	($0.15)	$168.68
Weighted average common shares outstanding - basic (in Shares)	5,233,308	9,599
Weighted average common shares outstanding - diluted (in Shares)	5,233,308	13,001

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Changes in Stockholdersb Deficit (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
In Thousands, except Share data		USD ($)	USD ($)	USD ($)
Balance at Dec. 31, 2014		$15,000	($23,734)	($8,734)
Shares (in Shares) at Dec. 31, 2014	307
Net loss			-809	-809
Issuance of common stock for partial conversion of notes payable and accrued interest		274		274
Issuance of common stock for partial conversion of notes payable and accrued interest (in Shares)	20,970
Issuance of common stock for cashless exercise of warrants		7		7
Issuance of common stock for cashless exercise of warrants (in Shares)	9,525
Reclassification of conversion option liabilities of notes payable		82		82
Balance at Mar. 31, 2015		$15,363	($24,543)	($9,180)
Shares (in Shares) at Mar. 31, 2015	30,802

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net (loss) income	($809)	$4,625
Adjustments to reconcile net loss to net cash used in operating activites:
Stock-based compensation		173
Deprecation and amortization	47	149
Amortization of debt discount and deferred financing fees	273	454
Change in fair value of subordinated convertible debt	-91	-2,432
Change in fair value of conversion options embedded in convertible notes	-182	-1,070
Change in fair value of warrants	-293	-3,123
Loss on settlement of other receivable		56
Increase (decrease) in cash attributable to changes in operating assets and liabilities:
Accounts payable and accrued expenses	648	661
Other receivable		115
Other current assets	12	-27
Accounts receivable	-49
Inventory	-15
Other assets		-62
Net cash used in operating activities	-459	-481
Net cash used in investing activities		-1
Cash flows from financing activities:
Proceeds from the issuance of notes payable and warrants	45	471
Repayment of notes payable	-33
Proceeds from the issuance of convertible debt	386
Net cash provided by financing activities	398	471
Net decrease in cash	-61	-11
Cash and cash equivalents - beginning of year	77	13
Cash and cash equivalents - end of year	$16	$2

Note_1_Organization_Basis_of_P

Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	1. ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SELECTED SIGNIFICANT ACCOUNTING POLICIES
	Organization and Basis of Presentation
	These unaudited condensed consolidated financial statements and notes thereto, include the financial statements of VeriTeQ Corporation (“VC” or the "Company"), a Delaware corporation, and its wholly-owned subsidiary, VeriTeQ Acquisition Corporation (“VAC”), a Florida corporation. VC, VAC and VAC’s subsidiaries are referred to together as “VeriTeQ” or “the Company.” The Company’s business consists of ongoing efforts to provide implantable medical device identification.
	The accompanying unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014. These condensed consolidated interim financial statements have been prepared in accordance the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (the “SEC”) and therefore omit or condense certain footnotes and other information normally included in consolidated interim financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments) considered necessary for the fair presentation of the condensed consolidated interim financial statements have been made. Results of operations reported for interim periods may not be indicative of the results for the entire year.
	During the three months ended March 31, 2015 and 2014, comprehensive loss/income was equal to the net loss/income amounts presented for the respective periods in the accompanying condensed consolidated interim statements of operations. In addition, certain prior year balances have been reclassified to conform to the current presentation.
	Going Concern
	The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The Company has incurred significant operating losses since its inception on December 14, 2011 and had a working capital deficit and accumulated deficit at March 31, 2015 of $7.9 million and $24.5 million, respectively. The Company’s cash position is critically deficient, and payments essential to the Company’s ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund the Company’s operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on the Company’s financial condition. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to the classification of recorded asset amounts or the amounts and classification of liabilities that might result from this uncertainty. The auditor’s report on the Company’s financial statements for the years ended December 31, 2014 and 2013 expressed substantial doubt about the Company’s ability to continue as a going concern.
	The Company needs to raise additional funds immediately and continue to raise funds until it begins to generate sufficient cash through the sale of its products to fund its operations, and it may not be able to obtain the necessary financing on acceptable terms, or at all. During the three months ended March 31, 2015, the Company raised approximately $0.4 million from the issuance of convertible promissory notes (see note 4).
	The Company had a working capital deficit at March 31, 2015 and in order to operate its business for the next twelve months and beyond, the Company is attempting to generate sufficient cash from: (i) the sale of its equity securities; (ii) the issuance of additional promissory notes; (iii) its business operations; (iv) other investing and financing sources, including loans from related parties; and (v) other cash management initiatives, including working with the Company’s vendors and service providers to continue to allow for extended payment terms.
	Reverse Stock Split and Change in Par Value of Common Stock
	On December 18, 2014, an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse split of all of the outstanding shares of the Company’s common stock at a ratio of 1 for 1,000 (the “Reverse Stock Split”) was approved by the Company’s Stockholders. The Certificate of Amendment became effective on February 11, 2015, and at that time the Reverse Stock Split took place and each 1,000 shares of outstanding common stock of the Company was combined and automatically converted into one share of the Company’s common stock, with a par value of $0.00001 per share. In addition, the conversion and exercise prices of all of the Company’s outstanding preferred stock, common stock purchase warrants, stock options and convertible notes payable were proportionately adjusted at the 1:1,000 reverse split ratio consistent with the terms of such instruments. No fractional shares were issued as a result of the Reverse Stock Split, and shareholders received a cash payment in lieu of such fractional shares that they would otherwise be entitled.
	Also on December 18, 2014, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to (i) reduce the par value of the Company’s common stock from $0.01 per share to $0.00001 per share; and (ii) increase the number of shares of common stock that the Company is authorized to issue from 500 million to 10 billion. This amendment became effective on December 18, 2014.
	All share, per share and capital stock amounts for the three months ended March 31, 2014 have been restated to give effect to the Reverse Stock Split and to the change in the par value of the Company’s common stock.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the year. Actual results could be affected by those estimates. Included in these estimates are assumptions used in determining the lives of long-lived assets, in valuation models used in estimating the fair value of certain promissory notes, warrants, embedded conversion options and convertible preferred stock, stock-based compensation, royalty obligations and in determining valuation allowances for deferred tax assets.
	Inventory
	Inventory consisted of purchased finished goods at March 31, 2015 and December 31, 2014. Inventory is valued at the lower of the value using the first-in, first-out (“FIFO”) cost method, or market.
	Property and Equipment
	Property and equipment consists primarily of machinery and computer equipment and is stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over the estimated useful life of the related assets, generally ranging from 3 to 10 years. Depreciation expense for the three-months ended March 31, 2015 and 2014 was approximately $2,000 and $1,000, respectively.
	Intangible Assets
	The Company’s intangible assets (see note 2) are amortized on a straight-line basis over their expected economic lives ranging from 7 to 14 years. The lives were determined based upon the expected use of the asset, the ability to extend or renew patents, trademarks and other contractual provisions associated with the asset, the stability of the industry, expected changes in and replacement value of distribution networks and other factors deemed appropriate. The Company reviews its intangible assets and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. If an impairment indicator is present, the Company evaluates recoverability by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If the carrying value of the asset exceeds the projected undiscounted cash flows, the Company is required to estimate the fair value of the asset and recognize an impairment charge to the extent that the carrying value of the asset exceeds its estimated fair value. The Company did not record any impairment charges during the three months ended March 31, 2015 and 2014.
	Revenue Recognition
	Product revenue is recognized at the time product is shipped and title has transferred, provided that a purchase order has been received or a contract has been executed, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable and collectability is deemed probable. If uncertainties regarding customer acceptance exist, the Company generally recognizes the revenue when such uncertainties are resolved. There are no significant post-contract support obligations at the time of revenue recognition. The Company’s accounting policy regarding vendor and post contract support obligations is based on the terms of the customers’ contracts and is billable upon occurrence of the post-sale support. Currently, there are no multiple element arrangements in connection with the Company’s product sales. Cost of products sold is recorded as the related revenue is recognized.
	Income Taxes
	The Company recognizes deferred tax liabilities and assets based on the temporary differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates in effect for the year in which the differences are expected to affect taxable income. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes consist primarily of timing differences such as amortization of intangible assets, deferred officers' compensation and stock-based compensation. A valuation allowance is provided against net deferred tax assets when the Company determines it is more likely than not that it will fail to generate sufficient taxable income to be able to realize the deferred tax assets.
	In accordance with U.S. GAAP, the Company is required to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Derecognition of a tax benefit previously recognized could result in the Company recording a tax liability that would reduce net assets. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of March 31, 2015 and December 31, 2014.
	Loss per Common Share and Common Share Equivalent
	Basic loss per share excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the Company. A reconciliation of the numerator and denominator used in determining (loss) income per share for the three months ended March 31, 2015 and 2014 is as follows:
	(in thousands, except share and per share amounts)	2015			2014
	Basic (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Basic weighted-average shares outstanding		5,233,308			9,599
	(Loss) income per share - basic	$	(0.15	)	$	481.82
	Numerator for diluted (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Less: income associated with change in fair value of convertible note		-			(2,432	)
	Net (loss) income for diluted (loss) income per share calculation	$	(809	)	$	2,193
	Denominator for diluted (loss) income per share:
	Basic weighted-average shares outstanding		5,233,308			9,599
	Stock options		-			1,096
	Warrants		-			40
	Shares issuable upon conversion of promissory notes		-			2,266
			5,233,308			13,001
	(Loss) income per share - diluted	$	(0.15	)	$	168.68
	The following securities were excluded in the computation of dilutive loss per share for the three months ended March 31, 2015 and 2014 because their inclusion would have been anti-dilutive:
		31-Mar-15			31-Mar-14
	Stock options		2,197			1,361
	Warrants		2,657,952,539			3,285
	Shares issuable upon conversion of preferred stock		582,594,937			-
	Shares issuable upon conversion of convertible notes payable		3,253,454,688			2,422
			6,494,004,361			7,068
	Impact of Recently Issued Accounting Standards
	From time to time, the Financial Accounting Standards Board (the “FASB”) or other standards setting bodies will issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC”) are communicated through issuance of an Accounting Standards Update (“ASU”).
	In April of 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30);Simplifying the Presentation of Debt Issuance Costs, which is effective for fiscal years beginning after December 15, 2015. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt, consistent with debt discounts. Early adoption is permitted. The Company does not believe that adoption of this ASU will have a material impact on its consolidated financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”), which is effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Under ASU 2014-15, entities will be required to formally assess their ability to continue as a going concern and provide disclosures under certain circumstances. While current practice regarding such disclosures is often guided by U.S. auditing standards, the new standard explicitly requires the assessment at interim and annual periods, and provides management with its own disclosure guidance. The standard can be adopted early. The Company is currently assessing the impact that adopting these new assessment and disclosure requirements will have on its financial statements and footnote disclosures. See note 1 for the Company’s current disclosure about its ability to continue as a going concern.
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. ASU 2014-09 is effective for public entities for annual reporting periods beginning after December 15, 2016 and interim periods within those periods. Early adoption is not permitted. The FASB has proposed a one-year deferral of the effective date with the option to early adopt using the original effective date. Entities may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company is currently assessing the impact that adopting this new accounting guidance will have on its consolidated financial statements and footnote disclosures.

Note_2_Intangible_Assets

Note 2 - Intangible Assets	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	2. INTANGIBLE ASSETS
	Intangible assets consist of the following:
			31-Mar-15									31-Dec-14
			Gross Carrying				Accumulated					Gross Carrying		Accumulated
	($000's)		Amount				Amortization			Total		Amount		Amortization			Total
	Proprietary Technology		$	1,500			$	(345	)	$	1,155	$	1,500	$	(318	)	$	1,182
	Customer relationship			500				(230	)		270		500		(212	)		288
			$	2,000			$	(575	)	$	1,425	$	2,000	$	(530	)	$	1,470
	Amortization of intangibles charged against income amounted to $45,000 and $0.1 million for the three-months ended March 31, 2015 and 2014, respectively. Estimated future aggregate amortization expense is as follows for the periods indicated:
				($000's)
	Remainder of the year	2015		$	(134	)
	Year ending December 31:	2016			(179	)
		2017			(179	)
		2018			(179	)
		2019			(109	)

Note_3_Accrued_Expenses

Note 3 - Accrued Expenses	3 Months Ended
	Mar. 31, 2015
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]
Other Liabilities Disclosure [Text Block]	3. ACCRUED EXPENSES
	The following table summarizes the significant components of accrued expenses:
		March 31,		December 31,
		2015		2014
		(in thousands)
	Accrued payroll and payroll related (including $576 and $1,060 to related parties)	$	896	$	1,204
	Accrued legal		466		477
	Accrued other expenses (including $131 and $111 to related parties)		967		830
	Total accrued expenses	$	2,329	$	2,511
	On March 3, 2015, the Company entered into separate agreements with Scott Silverman, the Company’s Chief Executive Officer, Randolph Geissler, the Company’s President, Michael Krawitz, the Company’s Chief Legal and Financial Officer and one other executive officer, (collectively, the “Executive Officers”) whereby each Executive Officer agreed that certain amounts of accrued but unpaid compensation that each individual was entitled to receive would be paid in the form of a convertible promissory note (the “Officer Notes”). In connection with these agreements, the Company issued Officer Notes to Messrs. Silverman, Geissler, Krawitz and the other executive officer in the principal amount of $194,010, $285,000, $267,500 and $50,000, respectively, resulting in a corresponding reduction in accrued expenses.

Note_4_Notes_Payable

Note 4 - Notes Payable	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	4. NOTES PAYABLE
	Notes payable at March 31, 2015 and December 31, 2014 consist of the following:
		31-Mar-15			31-Dec-14
		(in thousands)
	Convertible notes payable with a bifurcated conversion option ($206 past due)		3,099			2,943
	Related party and Officer notes		978			169
	Other notes payable ($61 past due)		176			185
	Discount on notes payable		(594	)		(531	)
			3,659			2,766
	Less current portion		(3,365	)		(2,480	)
	Non-current notes payable		294			286
	Convertible Notes with a Bifurcated Conversion Option
	During the three months ending March 31, 2015, the Company issued convertible promissory notes in the aggregate principal amount of $416,500, and received net proceeds of $386,000. These notes are generally due one year after the date of issuance, bear interest at rates of 1% to 12% per annum, and are convertible into shares of common stock at 57% to 61% of the market price of the Company’s common stock based on the low end of the trading range of the common stock during the 10 to 30 days prior to conversion, depending on the specific note being converted.
	With respect to the foregoing notes, in the event the Company were to issue or sell, or is deemed to have issued or sold, any shares of common stock for a consideration per share (the “New Issuance Price”) that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale (a “Dilutive Issuance”), then, immediately after such Dilutive Issuance, the conversion price then in effect is reduced to an amount equal to the New Issuance Price.
	In connection with the issuance of one of the foregoing notes, the Company issued a warrant to purchase 500,000 shares of the Company’s common stock at an exercise price of $.021 per share, subject to adjustment for stock splits, stock dividends and stock combinations (the “March 2015 Warrant”). The March 2015 Warrant is exercisable at any time until three years after the date of issuance. The terms of the warrant provides for a proportional downward adjustment of the exercise price in the event that the Company issues or sells, or is deemed to have issued or sold, shares of common stock at an issuance price that is less than the market price of the common stock at the time of issuance, as defined in the warrant agreement. The Company determined that the fair value of the March 2015 Warrant was de minimus at the date of issuance and at March 31, 2015.
	During the three months ending March 31, 2015, $260,607 of previously issued convertible notes, along with $2,487 of accrued interest, were converted into 20,861,540 shares of the Company’s common stock in accordance with their terms, and the outstanding balance on these remaining notes was $3,099,285 at March 31, 2015.
	Related Party Notes Payable
	On January 23, 2015, the Company borrowed $45,000 from Scott Silverman, as evidenced by a promissory note (the “2015 Silverman Note”). The 2015 Silverman Note is payable on demand and bears interest at a rate of 5% per annum. Between January 30, 2015 and March 31, 2015, the Company repaid $33,000 of this note to Mr. Silverman, and the outstanding balance on the 2015 Silverman Note as of March 31, 2015 was $12,000.
	As discussed in note 3, on March 3, 2015, four of the Company’s executive officers entered into agreements with the Company whereby certain amounts of accrued but unpaid compensation that each individual was entitled to receive would be paid in the form of Officer Notes, and the Company issued an aggregate of $796,510 of Officer Notes on March 3, 2015 in satisfaction of the accrued liabilities. In addition, Mr. Geissler and Mr. Krawitz agreed to have their previously issued and outstanding demand notes due from the Company, in the principal amounts of $34,000 and $60,000, respectively, converted into separate Officer Notes. The Officer Notes bear interest at a rate of 5% per annum, with principal and interest due on March 1, 2016.
	The Company has the option to prepay the Officer Notes, in whole or in part, and without premium or penalty, at any time upon 5 business days’ written notice to the holder. At any time after September 1, 2015, the holder of an Officer Note can convert all or part of the note into shares of the Company’s common stock at a conversion price equal to the average daily closing price of the Company’s common stock for the 10 days prior to conversion.
	On April 16, 2014 and May 1, 2014, the Company issued promissory notes to Ned L. Siegel in the principal amount of $30,000 and $20,000, respectively (collectively, the “Siegel Notes”), with interest accruing at a rate of 9% per annum and with principal and interest due on these notes one year after their date of issuance. Mr. Siegel was appointed a director of the Company on June 17, 2014, and resigned from the Company’s board of directors on January 28, 2015. On February 27, 2015, the Siegel Notes were amended to (i) extend the maturity date to March 1, 2016, and (ii) effective September 1, 2015, reduce the per share conversion price from $350 to 60% of the average of the three lowest closing prices of the Company’s common stock for the 10 trading days prior to conversion.
	Other Notes Payable
	Other notes payable as of December 31, 2014 consisted of a note payable to PositiveID Corporation in the principal amount of approximately $115,000 (the “PSID Note”) which is to be repaid through the issuance of 88 shares of the Company’s stock, and other promissory notes with an aggregate principal amount of $70,625 that are generally convertible into shares of the Company’s common stock at the option of the holder at a conversion price of $350 per share. For some of these notes, the Company may, at its sole option, elect to convert the note into common stock at a conversion price that is equal to 60% of the market price of the Company’s common stock, as defined in the notes. During the three months ended March 31, 2015, $9,400 of these notes, plus $1,537 of accrued interest, was converted into 108,527 shares of the Company’s common stock.
	At March 31, 2015, the total of all of the Company’s outstanding promissory notes was convertible into an aggregate of 3,253,454,688 shares of the Company’s common stock. The scheduled payments due based on maturities of current and long-term debt and at March 31, 2015 are presented in the following table:
	Year:	Amount
		(in thousands)
	2015		3,791
	2016		347
	Total payments	$	4,138	*
	* - Excludes $115,000 outstanding under the PSID Note which can only be settled through the issuance of 88 shares of the Company’s common stock.
	During the three months ended March 31, 2015 and 2014, the Company recognized interest expense of approximately $0.3 million and $0.5 million, respectively, which is primarily related to the amortization of debt discounts.

Note_5_Subordinated_Debt_Repor

Note 5 - Subordinated Debt Reported at Fair Value	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	5. SUBORDINATED DEBT REPORTED AT FAIR VALUE
	In December 2012, VAC entered into an asset purchase agreement and royalty agreement with SNC Holding Corp. wherein VAC acquired various technology and trademarks related to its radiation dose measurement technology. Under the terms of the agreements, VAC issued a non-interest bearing secured subordinated convertible promissory note in the principal amount of $3.3 million (the “SNC Note”). The SNC Note is convertible into one-third of the beneficial common stock ownership of VC held by Scott Silverman, or 2,148 shares as of March 31, 2015 and December 31, 2014, and was amended in July 2013 to extend the maturity date to June 2015.
	The Company made an irrevocable election at the time of issuance to report the note at fair value, with changes in fair value recorded through the Company’s statement of operations as Other expense/income in each accounting period. At March 31, 2015 and December 31, 2014, the fair value of the SNC Note was $0.2 million and $0.3 million, respectively (see note 6 for further information).

Note_6_Financial_Instruments_a

Note 6 - Financial Instruments and Fair Value Measurements	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Financial Instruments Disclosure [Text Block]	6. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
	Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.
	The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
	Level 1 – Quoted prices in active markets for identical assets or liabilities.
	Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
	As of March 31, 2015, the convertible note issued to SNC Holdings Corp. (which the Company elected to be accounted for at fair value), the bifurcated embedded option in other convertible notes and the warrant liabilities were valued using Level 3 inputs. The changes in fair value of the convertible note, the bifurcated embedded option in the convertible notes and the warrant liability during the three months ended March 31, 2015 and 2014 are reflected in the changes in fair value of derivative instruments in the Company’s consolidated statement of operations.
	As of March 31, 2015, a probability weighted expected return method (“PWERM”) was used to estimate the total enterprise value of approximately $2.5 million. For the PWERM analysis, the Company assumed four scenarios: (a) income approach scenario where the Company raises substantially all of the financing required within 6 months to carry out its plans to bring its products to market and an assumed probability of 15% due to lack of success in raising such funding to date; (b) market approach scenario with the likelihood of a sale or merger of the Company within 2 years, and an assumed probability of 15%; (c) continued operations scenario where the Company maintains the current operating levels with minimal financing, and an assumed probability of 30%, and (d) dissolution of the Company, and an assumed probability of 40%.
	An Option Pricing Method allocation model (“OPM”) was used to allocate the estimated enterprise value to the debt and equity tranches within the Company’s capitalization structure which resulted in a per share common stock value of $0.0001. A Monte Carlo simulation model was used to estimate the value impact of multiple future financings. The total values of the various debt and equity securities in the Company generated from the above valuation methodologies were allocated to the total estimated enterprise value of $2.5 million.
	The following table summarizes our financial assets and liabilities measured at fair value as presented in the consolidated balance sheets as of March 31, 2015 and December 31, 2014 (in thousands):
		31-Mar-15									31-Dec-14
		Level 1			Level 2			Level 3			Level 1			Level 2		Level 3
	Liabilities:
	SNC Note	$	—		$	—		$	225		$	—		$	—	$	316
	Bifurcated option in convertible notes	$	—		$	—		$	951		$	—		$	—	$	930
	Warrant liabilities	$	—		$	—		$	234		$	—		$	—	$	534
	Royalty obligations	$	—		$	—		$	600		$	—		$	—	$	600
	The following is a summary of activity of Level 3 liabilities for the three months ended March 31, 2015:
		SNC Note			Bifurcated			Warrant			Royalty
					embedded			liabilities			obligations
					option in
					convertible
					notes
	Balance at December 31, 2014	$	316		$	930		$	534		$	600
	Issuance of additional debt					285						-
	Conversion of notes and exercise of warrants into shares of common stock					(82	)		(7	)		-
	Gains included in net loss		(91	)		(182	)		(293	)		-
	Balance at March 31, 2015	$	225		$	951		$	234		$	600	**
	** Includes $160,000 of current royalty obligations included in accounts payable and accrued expenses at March 31, 2015 and December 31, 2014.

Note_7_Stockholders_Deficit

Note 7 - Stockholders' Deficit	3 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	7. STOCKHOLDERS’ DEFICIT
	Preferred Stock
	As of March 31, 2015, the Company has authorized 5 million shares of preferred stock, par value $0.01 per share with 1,841 shares of Series D Convertible Preferred Stock (the “Series D Preferred Stock”) outstanding, of which 1,400 shares are held by Scott Silverman and 441 shares are held by Randolph Geissler. The stated value of the Series D Preferred Stock is reflected as temporary equity in the Company’s consolidated balance sheet. On March 13, 2015, the Company’s Board of Directors approved an amendment to the Certificate of Designation for the Series D Preferred Stock to change the price for which the Series D Preferred Stock can be converted into common stock of the Company to the average closing price of the common over any 5 consecutive Trading Days occurring between March 12, 2015 and the conversion date, with the five-day period being elected by the holder of the Series D Preferred Stock in the conversion notice.
	Common Stock
	As previously discussed in note 1, an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect the 1:1,000 Reverse Stock Split became effective on February 11, 2015. All share, per share and capital stock amounts have been restated for the three months ended March 31, 2014 to give effect to the Reverse Stock Split.
	As of March 31, 2015 the Company had 10 billion shares of common stock authorized and 30,802,114 shares were issued and outstanding.
	Warrants Treated as Equity
	Warrants exercisable for shares of common stock and which qualify for equity treatment as of March 31, 2015 and December 31, 2014 are as follows:
	Series/ Issue Date	Number of			Exercise Price			Exercisable Period (years)
		Outstanding
		Warrants
	Series B / September 2012		39		$	1,572.06			3
	Series C / October 2012		19		$	1,572.06			3
	Series C / October 2012, reset May 2014		19		$	350			3
	Series D / December 2012		14		$	1,572.06			5
	Series E /December 2012		28		$	1,572.06			5
	Series F / March 2013		39		$	1,572.06			3
	Series G / April 2013		47		$	1,310.05			3
	Series G / April 2013, reset May 2014		47		$	350			3
	Series H / June 2013		61		$	1,572.06			3
	Series H / June 2013, reset May 2014		19		$	350			3
	Series I/May 2014		300		$	350			3
	Series J/May 2014		100		$	350			2
	Total		732
	Warrants Treated as Liabilities
	On November 13, 2013 in connection with the issuance of senior convertible notes, the Company issued warrants to purchase up to 2,644 shares of our common stock (the “November 2013 Warrants”). The November 2013 Warrants became exercisable at issuance and entitle the Investors to purchase shares of the Company’s common stock for a period of five years at an initial exercise price of $2,840 per share, and contain a cashless exercise provision. The exercise price is also subject to adjustment for stock dividends, stock splits and stock combinations. In addition, the exercise price of the warrant is subject to downward adjustment in the event the Company issues common stock or securities convertible into common stock at an issuance price or conversion price that is less than the exercise price of the November 2013 Warrants. Moreover, the November 2013 Warrants provide that the holder of the warrant has the right to invest the same aggregate amount, regardless of changes in the price of the Company’s common stock. Accordingly, decreases in the price of the Company’s common stock result in an increase in the number of shares exercisable under the Warrants.
	As a result of the issuances of promissory notes with variable conversion price formulas over the course of fiscal 2014 and 2015, the reset provisions under the terms of warrants have been triggered. Because the variable price formula changes with the value of the Company’s common stock, the number of shares subject to warrant varies.  As of March 31, 2015, if all of the remaining November 2013 Warrants had been exercised under the alternative price formulation the number of shares of the Company’s common stock that would have been issued would have been 2,657,451,807 shares based on an exercise price of $0.00108 per share, subject to adjustment for the cashless exercise provisions.
	During the three months ended March 31, 2015, the Company issued the March 2015 Warrant (see note 4). The March 2015 Warrant is exercisable at any time until three years after the date of issuance. The terms of the warrant provides for a proportional downward adjustment of the exercise price in the event that the Company issues or sells, or is deemed to have issued or sold, shares of common stock at an issuance price that is less than the market price of the common stock at the time of issuance, as defined in the warrant agreement. The Company determined that the fair value of the March 2015 Warrant was de minimus at the time of issuance and at March 31, 2015.
	The terms of the March 2015 Warrant and the November 2013 Warrants are such that they do not qualify for equity treatment under ASC 815 and are classified as liabilities in accordance with ASC 480 at March, 31, 2015 and December 31, 2014. The carrying amount of the warrant liabilities approximate management’s estimate of their fair value (see note 6) and were determined to be $0.2 million and $0.5 million at March 31, 2015 and March 31, 2014, respectively. The Company recognized a gain on the change in fair value of the Company’s warrant liabilities for the three months ended March 31, 2015 and 2014 of $0.3 million and $3.1 million, respectively.
	Stock Options
	On February 24, 2015, the Company’s board of directors approved a decrease in the number of shares reserved for issuance under the VeriTeQ Corporation 2014 Stock Incentive Plan (the “2014 Plan”) from 500,000,000 to 250,000,000. No option grants were issued under the 2014 Plan or any of the Company’s other equity based incentive plans during the three months ended March 31, 2015, and no compensation cost was recognized with respect to stock option grants for the three months ended March 31, 2015 and 2014, as all outstanding stock options were fully vested on or before January 1, 2014.
	A summary of the stock option activity for our stock options plans for the three months ended March 31, 2015 is as follows:
		Stock			Weighted
		Options			Average
					Exercise
					Price
	Outstanding at January 1, 2015		2,203		$	5,188
	Granted		—			—
	Exercised		—			—
	Forfeited or expired		(6	)	$	871,200
	Outstanding at March 31, 2015		2,197		$	2,823	*
	Vested or expected to vest at March 31, 2015		2,197		$	2,823	*
	* - The weighted average contractual life for exercisable options is 3.91 years.
	Restricted Stock Grants
	On June 17, 2014, the Company issued 650 shares of restricted stock to a director in connection with his appointment to the Company’s board of directors, of which 150 shares vested on January 2, 2015. The remaining shares were forfeit in 2015 due to this director’s resignation from the board of directors on January 28, 2015. In January 2013, the Company issued approximately 900 shares of restricted common stock to a member of its senior management. This restricted stock vested in full in January 2015. During the three months ended March 31, 2015 and 2014, the Company recorded $0 and $0.2 million, respectively, in compensation expense related to the restricted stock.

Note_8_Income_Taxes

Note 8 - Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	8. INCOME TAXES
	The Company did not record an income tax provision or benefit for the three months ended March 31, 2015 and 2014. The Company has incurred losses since its inception and has provided a valuation allowance against its net operating loss carryforwards and other net deferred tax assets.

Note_9_Related_Party_Transacti

Note 9 - Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	9. RELATED PARTY TRANSACTIONS
	See notes 3, 4, 7 and 12 for disclosures regarding transactions with related parties.

Note_10_Commitments_and_Contin

Note 10 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	10. COMMITMENTS AND CONTINGENCIES
	In March 2013, VC appointed a liquidator and initiated the formal liquidation of its U.K. subsidiary, Signature Industries Limited (“Signature”), primarily related to its outstanding liabilities. VC used £40,000 (approximately $61,000) of the proceeds from the sale of Signature’s former division, Digital Angel Radio Communications Limited (“DARC”) to satisfy its estimated portion of Signature’s outstanding liabilities. However, additional claims submitted to the liquidator could result in the Company being required to pay additional amounts to cover its share of Signature’s outstanding liabilities. The Company has estimated a potential additional liability of approximately $159,000. The Company expects the liquidation process to be completed by the middle of 2015, although it could extend beyond the expected timeframe.
	On January 30, 2014, the Company and the buyers of DARC entered into a letter agreement under which the Company agreed to accept a payment of £62,000 (USD approximately $0.1 million) in full and final settlement of a deferred purchase price related to VC’s sale of DARC in March 2013. As a result, the Company recorded, a loss on the settlement of this receivable of approximately USD $55,000 in the three months ended March 31, 2014, which is reflected in Other expenses in the Company’s consolidated statement of operations. All of the other provisions (including, without limitation, the indemnities) agreed between VC, and/or the Buyers under the stock purchase agreement and any related documents remain in full force and effect.
	The Company has been informed by the New Jersey Department of Environmental Protection that a predecessor business sold a building in 2006 for which an environmental action has been claimed. The claim is being reviewed by the Company’s outside legal counsel, and the Company has not yet determined the impact on its financial condition, liquidity or cash flows, if any.

Note_11_Supplemental_Disclosur

Note 11 - Supplemental Disclosure of Cash Flow Information	3 Months Ended
	Mar. 31, 2015
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	11. SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
	Supplemental cash flow information for the three months ended March 31, 2015 and 2014 were as follows (in thousands):
		2015		2014
	Supplemental disclosure of cash flow information:
	Cash paid for interest		-		-
	Cash paid for income taxes		-		-
	Supplemental schedule of non-cash investing and financing activities:
	Notes payable and accrued liabilities converted into common stock		274		70
	Accrued liabilities satisfied through the issuance of convertible promissory notes		797		-
	Cashless exercises of common stock warrants		7		-

Note_12_Subsequent_Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	12. SUBSEQUENT EVENTS
	On April 20, 2015, the Company sold 5,263,158 shares of its common stock to a director of the Company for a purchase price of $10,000. The purchase price was based on the closing price of the Company’s common stock on April 19, 2015.
	On April 22, 2015, the Company sold 6,666,666 shares of its common stock to Mr. Silverman for $10,000. The purchase price was based on the closing price of the Company’s common stock on April 21, 2015.
	Between April 1, 2015 and May 15, 2015, the Company issued additional convertible promissory notes in the aggregate principal amount of $180,375, for which the Company received $157,500 in net proceeds. These notes are generally due one year after the date of issuance, bear interest at rates of 10 to 12% per annum, and are convertible into shares of common stock at 60% to 61% of the market price of the Company’s common stock based on the low end of the trading range of the common stock during the 10 to 30 days prior to conversion, depending on the specific note being converted.
	The foregoing notes contain terms similar to those of the convertible notes issued in November 2013 and in 2014, whereby in the event the Company were to issue or sell, or is deemed to have issued or sold, any shares of common stock for a consideration per share (the “New Issuance Price”) that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale (a “Dilutive Issuance”), then, immediately after such Dilutive Issuance, the conversion price then in effect is reduced to an amount equal to the New Issuance Price.
	Between April 1, 2015 and May 15, 2015, outstanding promissory notes in the principal amount of approximately $197,000, along with accrued interest of approximately $6,000, were converted into 1,210,273,121 shares of common stock. Also between April 1, 2015 and May 15, 2015, the Company issued 330,650,213 shares of common stock in connection with cashless exercises of outstanding warrants.
	On May 12, 2015, a director of the Company converted an outstanding note payable plus accrued interest in the amount of $26,483, as well as additional amounts owed to him in the amount of $32,101, into 195,281,085 shares of common stock. The number of shares issued was based on the closing price of the Company’s common stock on May 11, 2015.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Stockholders' Equity, Policy [Policy Text Block]	Reverse Stock Split and Change in Par Value of Common Stock
	On December 18, 2014, an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse split of all of the outstanding shares of the Company’s common stock at a ratio of 1 for 1,000 (the “Reverse Stock Split”) was approved by the Company’s Stockholders. The Certificate of Amendment became effective on February 11, 2015, and at that time the Reverse Stock Split took place and each 1,000 shares of outstanding common stock of the Company was combined and automatically converted into one share of the Company’s common stock, with a par value of $0.00001 per share. In addition, the conversion and exercise prices of all of the Company’s outstanding preferred stock, common stock purchase warrants, stock options and convertible notes payable were proportionately adjusted at the 1:1,000 reverse split ratio consistent with the terms of such instruments. No fractional shares were issued as a result of the Reverse Stock Split, and shareholders received a cash payment in lieu of such fractional shares that they would otherwise be entitled.
	Also on December 18, 2014, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to (i) reduce the par value of the Company’s common stock from $0.01 per share to $0.00001 per share; and (ii) increase the number of shares of common stock that the Company is authorized to issue from 500 million to 10 billion. This amendment became effective on December 18, 2014.
	All share, per share and capital stock amounts for the three months ended March 31, 2014 have been restated to give effect to the Reverse Stock Split and to the change in the par value of the Company’s common stock.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the year. Actual results could be affected by those estimates. Included in these estimates are assumptions used in determining the lives of long-lived assets, in valuation models used in estimating the fair value of certain promissory notes, warrants, embedded conversion options and convertible preferred stock, stock-based compensation, royalty obligations and in determining valuation allowances for deferred tax assets.
Inventory, Policy [Policy Text Block]	Inventory
	Inventory consisted of purchased finished goods at March 31, 2015 and December 31, 2014. Inventory is valued at the lower of the value using the first-in, first-out (“FIFO”) cost method, or market.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment
	Property and equipment consists primarily of machinery and computer equipment and is stated at cost less accumulated depreciation. Depreciation expense is computed using the straight-line method over the estimated useful life of the related assets, generally ranging from 3 to 10 years. Depreciation expense for the three-months ended March 31, 2015 and 2014 was approximately $2,000 and $1,000, respectively.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Intangible Assets
	The Company’s intangible assets (see note 2) are amortized on a straight-line basis over their expected economic lives ranging from 7 to 14 years. The lives were determined based upon the expected use of the asset, the ability to extend or renew patents, trademarks and other contractual provisions associated with the asset, the stability of the industry, expected changes in and replacement value of distribution networks and other factors deemed appropriate. The Company reviews its intangible assets and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. If an impairment indicator is present, the Company evaluates recoverability by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If the carrying value of the asset exceeds the projected undiscounted cash flows, the Company is required to estimate the fair value of the asset and recognize an impairment charge to the extent that the carrying value of the asset exceeds its estimated fair value. The Company did not record any impairment charges during the three months ended March 31, 2015 and 2014.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	Product revenue is recognized at the time product is shipped and title has transferred, provided that a purchase order has been received or a contract has been executed, there are no uncertainties regarding customer acceptance, the sales price is fixed and determinable and collectability is deemed probable. If uncertainties regarding customer acceptance exist, the Company generally recognizes the revenue when such uncertainties are resolved. There are no significant post-contract support obligations at the time of revenue recognition. The Company’s accounting policy regarding vendor and post contract support obligations is based on the terms of the customers’ contracts and is billable upon occurrence of the post-sale support. Currently, there are no multiple element arrangements in connection with the Company’s product sales. Cost of products sold is recorded as the related revenue is recognized.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company recognizes deferred tax liabilities and assets based on the temporary differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates in effect for the year in which the differences are expected to affect taxable income. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes consist primarily of timing differences such as amortization of intangible assets, deferred officers' compensation and stock-based compensation. A valuation allowance is provided against net deferred tax assets when the Company determines it is more likely than not that it will fail to generate sufficient taxable income to be able to realize the deferred tax assets.
	In accordance with U.S. GAAP, the Company is required to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Derecognition of a tax benefit previously recognized could result in the Company recording a tax liability that would reduce net assets. Based on its analysis, the Company has determined that it has not incurred any liability for unrecognized tax benefits as of March 31, 2015 and December 31, 2014.
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share and Common Share Equivalent
	Basic loss per share excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the Company. A reconciliation of the numerator and denominator used in determining (loss) income per share for the three months ended March 31, 2015 and 2014 is as follows:
	(in thousands, except share and per share amounts)	2015			2014
	Basic (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Basic weighted-average shares outstanding		5,233,308			9,599
	(Loss) income per share - basic	$	(0.15	)	$	481.82
	Numerator for diluted (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Less: income associated with change in fair value of convertible note		-			(2,432	)
	Net (loss) income for diluted (loss) income per share calculation	$	(809	)	$	2,193
	Denominator for diluted (loss) income per share:
	Basic weighted-average shares outstanding		5,233,308			9,599
	Stock options		-			1,096
	Warrants		-			40
	Shares issuable upon conversion of promissory notes		-			2,266
			5,233,308			13,001
	(Loss) income per share - diluted	$	(0.15	)	$	168.68
	The following securities were excluded in the computation of dilutive loss per share for the three months ended March 31, 2015 and 2014 because their inclusion would have been anti-dilutive:
		31-Mar-15			31-Mar-14
	Stock options		2,197			1,361
	Warrants		2,657,952,539			3,285
	Shares issuable upon conversion of preferred stock		582,594,937			-
	Shares issuable upon conversion of convertible notes payable		3,253,454,688			2,422
			6,494,004,361			7,068
New Accounting Pronouncements, Policy [Policy Text Block]	Impact of Recently Issued Accounting Standards
	From time to time, the Financial Accounting Standards Board (the “FASB”) or other standards setting bodies will issue new accounting pronouncements. Updates to the FASB Accounting Standards Codification (“ASC”) are communicated through issuance of an Accounting Standards Update (“ASU”).
	In April of 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30);Simplifying the Presentation of Debt Issuance Costs, which is effective for fiscal years beginning after December 15, 2015. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the debt, consistent with debt discounts. Early adoption is permitted. The Company does not believe that adoption of this ASU will have a material impact on its consolidated financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”), which is effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. Under ASU 2014-15, entities will be required to formally assess their ability to continue as a going concern and provide disclosures under certain circumstances. While current practice regarding such disclosures is often guided by U.S. auditing standards, the new standard explicitly requires the assessment at interim and annual periods, and provides management with its own disclosure guidance. The standard can be adopted early. The Company is currently assessing the impact that adopting these new assessment and disclosure requirements will have on its financial statements and footnote disclosures. See note 1 for the Company’s current disclosure about its ability to continue as a going concern.
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. ASU 2014-09 is effective for public entities for annual reporting periods beginning after December 15, 2016 and interim periods within those periods. Early adoption is not permitted. The FASB has proposed a one-year deferral of the effective date with the option to early adopt using the original effective date. Entities may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company is currently assessing the impact that adopting this new accounting guidance will have on its consolidated financial statements and footnote disclosures.

Note_1_Organization_Basis_of_P1

Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	(in thousands, except share and per share amounts)	2015			2014
	Basic (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Basic weighted-average shares outstanding		5,233,308			9,599
	(Loss) income per share - basic	$	(0.15	)	$	481.82
	Numerator for diluted (loss) income per share:
	Net (loss) income	$	(809	)	$	4,625
	Less: income associated with change in fair value of convertible note		-			(2,432	)
	Net (loss) income for diluted (loss) income per share calculation	$	(809	)	$	2,193
	Denominator for diluted (loss) income per share:
	Basic weighted-average shares outstanding		5,233,308			9,599
	Stock options		-			1,096
	Warrants		-			40
	Shares issuable upon conversion of promissory notes		-			2,266
			5,233,308			13,001
	(Loss) income per share - diluted	$	(0.15	)	$	168.68
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]		31-Mar-15			31-Mar-14
	Stock options		2,197			1,361
	Warrants		2,657,952,539			3,285
	Shares issuable upon conversion of preferred stock		582,594,937			-
	Shares issuable upon conversion of convertible notes payable		3,253,454,688			2,422
			6,494,004,361			7,068

Note_2_Intangible_Assets_Table

Note 2 - Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]			31-Mar-15									31-Dec-14
			Gross Carrying				Accumulated					Gross Carrying		Accumulated
	($000's)		Amount				Amortization			Total		Amount		Amortization			Total
	Proprietary Technology		$	1,500			$	(345	)	$	1,155	$	1,500	$	(318	)	$	1,182
	Customer relationship			500				(230	)		270		500		(212	)		288
			$	2,000			$	(575	)	$	1,425	$	2,000	$	(530	)	$	1,470
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]				($000's)
	Remainder of the year	2015		$	(134	)
	Year ending December 31:	2016			(179	)
		2017			(179	)
		2018			(179	)
		2019			(109	)

Note_3_Accrued_Expenses_Tables

Note 3 - Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2015
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]
Schedule of Accrued Liabilities [Table Text Block]		March 31,		December 31,
		2015		2014
		(in thousands)
	Accrued payroll and payroll related (including $576 and $1,060 to related parties)	$	896	$	1,204
	Accrued legal		466		477
	Accrued other expenses (including $131 and $111 to related parties)		967		830
	Total accrued expenses	$	2,329	$	2,511

Note_4_Notes_Payable_Tables

Note 4 - Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]		31-Mar-15			31-Dec-14
		(in thousands)
	Convertible notes payable with a bifurcated conversion option ($206 past due)		3,099			2,943
	Related party and Officer notes		978			169
	Other notes payable ($61 past due)		176			185
	Discount on notes payable		(594	)		(531	)
			3,659			2,766
	Less current portion		(3,365	)		(2,480	)
	Non-current notes payable		294			286
Schedule of Maturities of Long-term Debt [Table Text Block]	Year:	Amount
		(in thousands)
	2015		3,791
	2016		347
	Total payments	$	4,138	*

Note_6_Financial_Instruments_a1

Note 6 - Financial Instruments and Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Fair Value, by Balance Sheet Grouping [Table Text Block]		31-Mar-15									31-Dec-14
		Level 1			Level 2			Level 3			Level 1			Level 2		Level 3
	Liabilities:
	SNC Note	$	—		$	—		$	225		$	—		$	—	$	316
	Bifurcated option in convertible notes	$	—		$	—		$	951		$	—		$	—	$	930
	Warrant liabilities	$	—		$	—		$	234		$	—		$	—	$	534
	Royalty obligations	$	—		$	—		$	600		$	—		$	—	$	600
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]		SNC Note			Bifurcated			Warrant			Royalty
					embedded			liabilities			obligations
					option in
					convertible
					notes
	Balance at December 31, 2014	$	316		$	930		$	534		$	600
	Issuance of additional debt					285						-
	Conversion of notes and exercise of warrants into shares of common stock					(82	)		(7	)		-
	Gains included in net loss		(91	)		(182	)		(293	)		-
	Balance at March 31, 2015	$	225		$	951		$	234		$	600	**

Note_7_Stockholders_Deficit_Ta

Note 7 - Stockholders' Deficit (Tables)	3 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Series/ Issue Date	Number of			Exercise Price			Exercisable Period (years)
		Outstanding
		Warrants
	Series B / September 2012		39		$	1,572.06			3
	Series C / October 2012		19		$	1,572.06			3
	Series C / October 2012, reset May 2014		19		$	350			3
	Series D / December 2012		14		$	1,572.06			5
	Series E /December 2012		28		$	1,572.06			5
	Series F / March 2013		39		$	1,572.06			3
	Series G / April 2013		47		$	1,310.05			3
	Series G / April 2013, reset May 2014		47		$	350			3
	Series H / June 2013		61		$	1,572.06			3
	Series H / June 2013, reset May 2014		19		$	350			3
	Series I/May 2014		300		$	350			3
	Series J/May 2014		100		$	350			2
	Total		732
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]		Stock			Weighted
		Options			Average
					Exercise
					Price
	Outstanding at January 1, 2015		2,203		$	5,188
	Granted		—			—
	Exercised		—			—
	Forfeited or expired		(6	)	$	871,200
	Outstanding at March 31, 2015		2,197		$	2,823	*
	Vested or expected to vest at March 31, 2015		2,197		$	2,823	*

Note_11_Supplemental_Disclosur1

Note 11 - Supplemental Disclosure of Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2015
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]		2015		2014
	Supplemental disclosure of cash flow information:
	Cash paid for interest		-		-
	Cash paid for income taxes		-		-
	Supplemental schedule of non-cash investing and financing activities:
	Notes payable and accrued liabilities converted into common stock		274		70
	Accrued liabilities satisfied through the issuance of convertible promissory notes		797		-
	Cashless exercises of common stock warrants		7		-

Note_1_Organization_Basis_of_P2

Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) (USD $)	3 Months Ended		0 Months Ended
Share data in Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Feb. 11, 2015	Dec. 31, 2014	Dec. 18, 2014	Dec. 17, 2014
Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) [Line Items]
Working Capital (Deficit)	$7,900,000
Retained Earnings (Accumulated Deficit)	-24,543,000			-23,734,000
Proceeds from Convertible Debt	386,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$0.00			$0.00	$0.00	$0.01
Common Stock, Shares Authorized (in Shares)	10,000			10,000	10,000	500
Depreciation	2,000	1,000
Impairment of Intangible Assets, Finite-lived	0	0
Unrecognized Tax Benefits	$0			$0
Minimum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Finite-Lived Intangible Asset, Useful Life	7 years
Maximum [Member]
Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Finite-Lived Intangible Asset, Useful Life	14 years
Reverse Stock Split [Member]
Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) [Line Items]
Stockholders' Equity Note, Stock Split, Conversion Ratio			1,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)			$0.00

Note_1_Organization_Basis_of_P3

Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) - Basic and Diluted Loss Per Share (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Basic (loss) income per share:
Net (loss) income (in Dollars)	($809)	$4,625
Less: income associated with change in fair value of convertible note (in Dollars)		-2,432
Net (loss) income for diluted (loss) income per share calculation (in Dollars)	($809)	$2,193
Basic weighted-average shares outstanding	5,233,308	9,599
Stock options		1,096
Warrants		40
Shares issuable upon conversion of promissory notes		2,266
	5,233,308	13,001
(Loss) income per share - diluted (in Dollars per share)	($0.15)	$168.68
(Loss) income per share - basic (in Dollars per share)	($0.15)	$481.82

Note_1_Organization_Basis_of_P4

Note 1 - Organization, Basis of Presentation and Summary of Selected Significant Accounting Policies (Details) - Antidilutive Securities	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	6,494,004,361	7,068
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	2,197	1,361
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	2,657,952,539	3,285
If the Preferred Stock is Converted [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	582,594,937
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	3,253,454,688	2,422

Note_2_Intangible_Assets_Detai

Note 2 - Intangible Assets (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$45,000	$100,000

Note_2_Intangible_Assets_Detai1

Note 2 - Intangible Assets (Details) - Intangibles and Other Assets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Note 2 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]
Gross Carrying Amount	$2,000	$2,000
Accumulated Amortization	-575	-530
Total	1,425	1,470
Technology-Based Intangible Assets [Member]
Note 2 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]
Gross Carrying Amount	1,500	1,500
Accumulated Amortization	-345	-318
Total	1,155	1,182
Customer Relationships [Member]
Note 2 - Intangible Assets (Details) - Intangibles and Other Assets [Line Items]
Gross Carrying Amount	500	500
Accumulated Amortization	-230	-212
Total	$270	$288

Note_2_Intangible_Assets_Detai2

Note 2 - Intangible Assets (Details) - Amortization of Intangibles (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Amortization of Intangibles [Abstract]
	($134)
	-179
	-179
	-179
	($109)

Note_3_Accrued_Expenses_Detail

Note 3 - Accrued Expenses (Details) (Officer Notes [Member], USD $)	Mar. 03, 2015	Mar. 31, 2015
Note 3 - Accrued Expenses (Details) [Line Items]
Due to Related Parties		$796,510
Silverman [Member]
Note 3 - Accrued Expenses (Details) [Line Items]
Due to Related Parties	194,010
Geissler [Member]
Note 3 - Accrued Expenses (Details) [Line Items]
Due to Related Parties	285,000
Krawitz [Member]
Note 3 - Accrued Expenses (Details) [Line Items]
Due to Related Parties	267,500
Executive Officer [Member]
Note 3 - Accrued Expenses (Details) [Line Items]
Due to Related Parties	$50,000

Note_3_Accrued_Expenses_Detail1

Note 3 - Accrued Expenses (Details) - Significant Components of Accrued Expenses (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Significant Components of Accrued Expenses [Abstract]
Accrued payroll and payroll related (including $576 and $1,060 to related parties)	$896	$1,204
Accrued legal	466	477
Accrued other expenses (including $131 and $111 to related parties)	967	830
Total accrued expenses	$2,329	$2,511

Note_3_Accrued_Expenses_Detail2

Note 3 - Accrued Expenses (Details) - Significant Components of Accrued Expenses (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Significant Components of Accrued Expenses [Abstract]
Accrued payroll and payroll related, related parties	$576	$1,060
Accrued other expenses to related parties	$131	$111

Note_4_Notes_Payable_Details

Note 4 - Notes Payable (Details) (USD $)	3 Months Ended		2 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Dec. 31, 2014	Mar. 03, 2015	Jan. 23, 2015	Apr. 16, 2014	1-May-14	Oct. 31, 2013
Note 4 - Notes Payable (Details) [Line Items]
Proceeds from Convertible Debt	$386,000
Convertible Notes Payable	3,099,000		3,099,000	2,943,000
Notes Payable	3,659,000		3,659,000	2,766,000
Conversion of Stock, Shares Converted (in Shares)	3,253,454,688
Other Noncash Expense	273,000	454,000
Conversion of Principal Debt to Stock [Member] | Accredited Investors [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	9,400
Conversion of Principal Debt to Stock [Member] | Convertible Notes Issued Prior to First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	260,607
Conversion of Accrued Interest to Stock [Member] | Accredited Investors [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	1,537
Conversion of Accrued Interest to Stock [Member] | Convertible Notes Issued Prior to First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Original Debt, Amount	2,487
March 2015 Warrants [Member]
Note 4 - Notes Payable (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	500,000		500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$0.02		$0.02
Warrant Term	3 years
Silverman [Member] | Officer Notes [Member]
Note 4 - Notes Payable (Details) [Line Items]
Due to Related Parties					194,010
Silverman [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						5.00%
Debt Instrument, Face Amount						45,000
Repayments of Notes Payable			33,000
Notes Payable	12,000		12,000
Geissler [Member] | Officer Notes [Member]
Note 4 - Notes Payable (Details) [Line Items]
Due to Related Parties					285,000
Debt Instrument, Settlement of Prior Debt Included in Face Amount							34,000
Krawitz [Member] | Officer Notes [Member]
Note 4 - Notes Payable (Details) [Line Items]
Due to Related Parties					267,500
Debt Instrument, Settlement of Prior Debt Included in Face Amount							60,000
Ned Siegel [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage									9.00%
Debt Instrument, Face Amount							30,000	20,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)				$350
Accredited Investors [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	108,527
Debt Instrument, Face Amount				70,625
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$350		$350
Debt Instrument, Convertible, Conversion Price, Percent Of Lowest Trade Price	60.00%		60.00%	60.00%
PositiveID [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Face Amount				115,000
Debt Conversion, Converted Instrument, Shares to be Issued to Settle Debt (in Shares)				88
Minimum [Member] | Convertible Notes Issued in First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.00%		1.00%
Debt Instrument, Convertible, Conversion Rate	57.00%
Maximum [Member] | Convertible Notes Issued in First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%		12.00%
Debt Instrument, Convertible, Conversion Rate	61.00%
Convertible Notes Issued in First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Convertible Notes Payable, Current	416,500		416,500
Proceeds from Convertible Debt	386,000
Convertible Notes Issued Prior to First Quarter of Fiscal 2015 [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	20,861,540
Convertible Notes Payable	3,099,285		3,099,285
Officer Notes [Member]
Note 4 - Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							5.00%
Due to Related Parties	$796,510		$796,510

Note_4_Notes_Payable_Details_N

Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt (USD $)	Mar. 31, 2015	Dec. 31, 2014
Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt [Line Items]
Convertible notes payable with a bifurcated conversion option ($206 past due)	$3,099,000	$2,943,000
Related party and Officer notes	978,000	169,000
Other notes payable ($61 past due)	176,000	185,000
Discount on notes payable	-594,000	-531,000
	3,659,000	2,766,000
Less current portion	-3,365,000	-2,480,000
Non-current notes payable	294,000	286,000
Past Due [Member]
Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt [Line Items]
Convertible notes payable with a bifurcated conversion option ($206 past due)	206,000	206,000
Other notes payable ($61 past due)	$61,000	$61,000

Note_4_Notes_Payable_Details_N1

Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt (Parentheticals) [Line Items]
Convertible notes payable past due	$3,099,000	$2,943,000
Other notes payable past due	176,000	185,000
Past Due [Member]
Note 4 - Notes Payable (Details) - Notes Payable and Long-term Debt (Parentheticals) [Line Items]
Convertible notes payable past due	206,000	206,000
Other notes payable past due	$61,000	$61,000

Note_4_Notes_Payable_Details_M

Note 4 - Notes Payable (Details) - Maturities of Current and Long-term Debt (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Maturities of Current and Long-term Debt [Abstract]
2015	$3,791
2016	347
Total payments	$4,138	[1]
[1]	Excludes $115,000 outstanding under the PSID Note which can only be settled through the issuance of 88 shares of the Company's common stock.

Note_5_Subordinated_Debt_Repor1

Note 5 - Subordinated Debt Reported at Fair Value (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2012
Note 5 - Subordinated Debt Reported at Fair Value (Details) [Line Items]
Convertible Subordinated Debt, Noncurrent	225,000	316,000
Chief Executive Officer [Member] | Subordinated Debt [Member]
Note 5 - Subordinated Debt Reported at Fair Value (Details) [Line Items]
Debt Instrument, Face Amount			$3,300,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	2,148	2,148

Note_6_Financial_Instruments_a2

Note 6 - Financial Instruments and Fair Value Measurements (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Note 6 - Financial Instruments and Fair Value Measurements (Details) [Line Items]
Option Pricing Method, Enterpise Value, Per Share (in Dollars per share)	$0.00
Long-term Debt [Member]
Note 6 - Financial Instruments and Fair Value Measurements (Details) [Line Items]
Accrued Royalties	$160,000	$160,000
SNC Holding Corp. [Member]
Note 6 - Financial Instruments and Fair Value Measurements (Details) [Line Items]
PWERM Estimate of Enterprise Value	$2,500,000

Note_6_Financial_Instruments_a3

Note 6 - Financial Instruments and Fair Value Measurements (Details) - Assets and Liabilities Measured at Fair Value (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Liabilities:
Royalty obligations	$440	$440
Bifurcated Option in Convertible Notes [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities:
Derivative liabilities	951	930
Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities:
Derivative liabilities	234	534
Warrant [Member]
Liabilities:
Derivative liabilities	234	534
Fair Value, Inputs, Level 3 [Member]
Liabilities:
SNC Note	225	316
Royalty obligations	$600	$600

Note_6_Financial_Instruments_a4

Note 6 - Financial Instruments and Fair Value Measurements (Details) - Level 3 Liabilities Activity (USD $)	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Conversion of notes and exercise of warrants into shares of common stock	($7,000)
Estimated Royalty Obligations [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Royalty obligations			600,000
Royalty obligations	600,000	[1]	600,000
Warrant [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities	534,000
Conversion of notes and exercise of warrants into shares of common stock	-7,000
Gains included in net loss	-293,000
Derivative liabilities	234,000
SNC Note and PSID Note [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
SNC Note	316,000
Gains included in net loss	-91,000
SNC Note	225,000
Embedded Derivative Financial Instruments [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities	930,000
Issuance of additional debt	285,000
Conversion of notes and exercise of warrants into shares of common stock	-82,000
Gains included in net loss	-182,000
Derivative liabilities	$951,000
[1]	Includes $160,000 of current royalty obligations included in accounts payable and accrued expenses at March 31, 2015 and December 31, 2014.

Note_7_Stockholders_Deficit_De

Note 7 - Stockholders' Deficit (Details) (USD $)

0 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

Nov. 13, 2013

Mar. 31, 2015

Mar. 31, 2014

Jan. 02, 2015

Jun. 17, 2014

Jan. 31, 2013

Feb. 11, 2015

Dec. 31, 2014

Dec. 18, 2014

Dec. 17, 2014

Feb. 24, 2015

Feb. 23, 2015

Note 7 - Stockholders' Deficit (Details) [Line Items]

Preferred Stock, Shares Authorized

4,998,000

4,998,000

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$0.01

$0.01

Preferred Stock, Shares Outstanding

0

0

Common Stock, Shares Authorized

10,000,000,000

10,000,000,000

10,000,000,000

500,000,000

Common Stock, Shares, Issued

30,802,114

307,000

Common Stock, Shares, Outstanding

30,802,114

307,000

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

5 years

Warrants and Rights Outstanding (in Dollars)

$234,000

$500,000

$534,000

Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net (in Dollars)

182,000

1,070,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

0

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)

0

0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term

3 years 332 days

If Exercised Under Alternative Price Formulation [Member] | November 2013 Warrants [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

2,657,451,807

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$0.00

Restricted Stock [Member] | Director [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

650

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

150

Restricted Stock [Member] | Management [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

900

Restricted Stock [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Allocated Share-based Compensation Expense (in Dollars)

0

200,000

November 2013 Warrants [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

2,644,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

2,840

March 2015 Warrants [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

500,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$0.02

Warrant Term

3 years

Warrant [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net (in Dollars)

$300,000

$3,100,000

Silverman [Member] | Series D Preferred Stock [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Preferred Stock, Shares Outstanding

1,400

Geissler [Member] | Series D Preferred Stock [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Preferred Stock, Shares Outstanding

441

Series D Preferred Stock [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Preferred Stock, Shares Authorized

5,000,000

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$0.01

Preferred Stock, Shares Outstanding

1,841

2014 Stock Incentive Plan [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

250,000,000

500,000,000

Reverse Stock Split [Member]

Note 7 - Stockholders' Deficit (Details) [Line Items]

Stockholders' Equity Note, Stock Split, Conversion Ratio

1,000

Note_7_Stockholders_Deficit_De1

Note 7 - Stockholders' Deficit (Details) - Warrants Exercisable (Stockholders' Equity [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	732
Series B Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	39
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	3 years
Series C Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	19
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	3 years
Series C Warrant Reset [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	19
Exercise Price (in Dollars per share)	$350
Exercisable Period (Years)	3 years
Series D Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	14
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	5 years
Series E Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	28
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	5 years
Series F Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	39
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	3 years
Series G Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	47
Exercise Price (in Dollars per share)	$1,310.05
Exercisable Period (Years)	3 years
Series G Warrant Reset [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	47
Exercise Price (in Dollars per share)	$350
Exercisable Period (Years)	3 years
Series H Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	61
Exercise Price (in Dollars per share)	$1,572.06
Exercisable Period (Years)	3 years
Series H Warrant Reset [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	19
Exercise Price (in Dollars per share)	$350
Exercisable Period (Years)	3 years
Series I Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	300
Exercise Price (in Dollars per share)	$350
Exercisable Period (Years)	3 years
Series J Warrant [Member]
Class of Warrant or Right [Line Items]
Number of Outstanding Warrants	100
Exercise Price (in Dollars per share)	$350
Exercisable Period (Years)	2 years

Note_7_Stockholders_Deficit_De2

Note 7 - Stockholders' Deficit (Details) - Stock Option Activity (USD $)	3 Months Ended
	Mar. 31, 2015
Stock Option Activity [Abstract]
Stock options outstanding	2,203
Stock options outstanding - weighted average exercise price	$5,188
Vested or expected to vest at March 31, 2015	2,197
Vested or expected to vest at March 31, 2015	$2,823	[1]
Forfeited or expired	-6
Forfeited or expired	$871,200
Stock options outstanding	2,197
Stock options outstanding - weighted average exercise price	$2,823	[1]
[1]	The weighted average contractual life for exercisable options is 3.91 years.

Note_8_Income_Taxes_Details

Note 8 - Income Taxes (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$0	$0

Note_10_Commitments_and_Contin1

Note 10 - Commitments and Contingencies (Details)	1 Months Ended		3 Months Ended	0 Months Ended
	Mar. 31, 2013	Mar. 31, 2013	Mar. 31, 2014	Jan. 30, 2014	Jan. 30, 2014
	USD ($)	GBP (£)	Loss on Settlement [Member]	Settled Litigation [Member]	Settled Litigation [Member]
			USD ($)	Letter Agreement, Sale of DARC [Member]	Letter Agreement, Sale of DARC [Member]
				USD ($)	GBP (£)
Note 10 - Commitments and Contingencies (Details) [Line Items]
Portion of Purchase Price From Sale of Division to Satisfy Outstanding Liabilities	$61,000	£ 40,000
Business Combination, Contingent Consideration, Liability	159,000
Settlement of Deferred Purchase Price Receivable				100,000	62,000
Other Expenses			$55,000

Note_11_Supplemental_Disclosur2

Note 11 - Supplemental Disclosure of Cash Flow Information (Details) - Supplemental Cash Flow Information (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Supplemental schedule of non-cash investing and financing activities:
Notes payable and accrued liabilities converted into common stock	$274	$70
Accrued liabilities satisfied through the issuance of convertible promissory notes	797
Cashless exercises of common stock warrants	$7

Note_12_Subsequent_Events_Deta

Note 12 - Subsequent Events (Details) (USD $)	3 Months Ended	1 Months Ended	0 Months Ended
	Mar. 31, 2015	15-May-15	12-May-15	Apr. 20, 2015	Apr. 22, 2015	Jan. 23, 2015
Note 12 - Subsequent Events (Details) [Line Items]
Proceeds from Convertible Debt	$386,000
Subsequent Event [Member] | Conversion of Principal Debt to Stock [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount		197,000
Subsequent Event [Member] | Conversion of Accrued Interest to Stock [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount		6,000
Subsequent Event [Member] | Conversion of Note Payable and Accrued Interest [Member] | Director [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount			26,483
Subsequent Event [Member] | Conversion of Other Debt [Member] | Director [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount			32,101
Subsequent Event [Member] | Director [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)				5,263,158
Proceeds from Issuance of Common Stock				10,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)			195,281,085
Subsequent Event [Member] | Silverman [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)					6,666,666
Proceeds from Issuance of Common Stock					10,000
Subsequent Event [Member] | Minimum [Member] | Convertible Notes Issued in Second Quarter of Fiscal 2015 [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Debt Instrument, Convertible, Conversion Rate		60.00%
Subsequent Event [Member] | Maximum [Member] | Convertible Notes Issued in Second Quarter of Fiscal 2015 [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Convertible, Conversion Rate		61.00%
Subsequent Event [Member] | Cashless Exercise of Warrants [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)		330,650,213
Subsequent Event [Member] | Convertible Notes Issued in Second Quarter of Fiscal 2015 [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Convertible Notes Payable, Current		180,375
Proceeds from Convertible Debt		$157,500
Subsequent Event [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		1,210,273,121
Silverman [Member]
Note 12 - Subsequent Events (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						5.00%